CAPRICOR THERAPEUTICS, INC.CAPR

Market cap
$1.2B
P/E ratio
Dec 31,
2011
Dec 31,
2013
Dec 31,
2014
Dec 31,
2015
Dec 31,
2016
Dec 31,
2017
Dec 31,
2018
Dec 31,
2019
Dec 31,
2020
Dec 31,
2021
Dec 31,
2022
Dec 31,
2023
Dec 31,
2024
Cash and cash equivalents128636443335101511
Marketable securities-326,494-813836--3225140
Receivables--360,233211,938223,335344,575204,86887,968-391,750547,5801010
Prepaid expenses and other current assets271,298222,763235,523210,603342,892501,164724,184571,38211919,892995,7762
TOTAL CURRENT ASSETS141214181681134364351163
PROPERTY AND EQUIPMENT, net9,74474,187229,455318,566435,336372,096574,206442,806850,8472566
Lease right-of-use assets, net---------3221
Other assets---70,14661,42695,969151,788119,60888,701275,722268,172268,172221,700
TOTAL ASSETS161416191691135415059170
Accounts payable and accrued expenses--23311875,67733568
Lease liabilities, current---------417,632682,039749,112834,799
Deferred revenue, current----------182412
TOTAL CURRENT LIABILITIES541,447267521897,99234243121
CIRM liability------------3
Lease liabilities, net of current---------221616,315
TOTAL LONG-TERM LIABILITIES-4141118333361554
TOTAL LIABILITIES-6201723554610383625
Preferred Stock, Value, Issued-------------
Common Stock, Value, Issued39,71211,68711,70716,25521,39926,27131,3885,22720,57724,18525,24131,14845,582
Additional paid-in capital--163450637181116139149182344
Accumulated other comprehensive income--980-9,3853,52411,62012,393-757--105,244235,8131
Accumulated deficit-44,814,980--22,315,127-35,172,466-53,979,242-51,547,819-66,738,914-74,380,731-88,037,759-108,060,279-137,079,811-159,367,353-200
TOTAL STOCKHOLDERS' EQUITY830,723-534,882-6,248,723-1,031,774-4,003,154115728311223145
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY161416191691135415059170